767
Participants
Start Date
December 31, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Short Acting Beta Agonist (SABA)
Participants requiring a spirometry measurement will be administered a SABA in a metered dose inhaler (MDI) during the reversibility assessments
GSK Investigational Site, Coffs Harbour
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Marseille
GSK Investigational Site, Berlin
GSK Investigational Site, Corning
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Dijon
GSK Investigational Site, Columbia
GSK Investigational Site, Baltimore
GSK Investigational Site, Hamburg
GSK Investigational Site, Lübeck
GSK Investigational Site, Schleswig
GSK Investigational Site, Shelby
GSK Investigational Site, Charlotte
GSK Investigational Site, Greenville
GSK Investigational Site, Tallahassee
GSK Investigational Site, Pessac
GSK Investigational Site, Grenoble
GSK Investigational Site, Owensboro
GSK Investigational Site, Nantes
GSK Investigational Site, Nantes
GSK Investigational Site, Cincinnati
GSK Investigational Site, Reims
GSK Investigational Site, Minneapolis
GSK Investigational Site, Plymouth
GSK Investigational Site, Lille
GSK Investigational Site, Bayonne
GSK Investigational Site, Tarbes
GSK Investigational Site, Strasbourg
GSK Investigational Site, Lyon
GSK Investigational Site, Villefranche-sur-Saône
GSK Investigational Site, Little Rock
GSK Investigational Site, Paris
GSK Investigational Site, Rouen
GSK Investigational Site, Munich
GSK Investigational Site, Gauting
GSK Investigational Site, Los Angeles
GSK Investigational Site, Rolling Hills Estates
GSK Investigational Site, Upland
GSK Investigational Site, San Diego
GSK Investigational Site, Riverside
GSK Investigational Site, Newport Beach
GSK Investigational Site, Fresno
GSK Investigational Site, Medford
GSK Investigational Site, Sherwood Park
GSK Investigational Site, Brampton
GSK Investigational Site, Burlington
GSK Investigational Site, Grimsby
GSK Investigational Site, London
GSK Investigational Site, Mississauga
GSK Investigational Site, St-Charles-Borromée
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Windsor
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Cottbus
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Birmingham
GSK Investigational Site, Birmingham
GSK Investigational Site, Cambridge
GSK Investigational Site, Crawley
GSK Investigational Site, Liverpool
GSK Investigational Site, London
GSK Investigational Site, Middlesbrough
GSK Investigational Site, Radstock, Bath
GSK Investigational Site, Salford
GSK Investigational Site, Trowbridge
Lead Sponsor
GlaxoSmithKline
INDUSTRY